CRB-913: A Novel Oral Cannabinoid Receptor-1 (CB-1) Inverse Agonist Enhances Tirzepatide and Semaglutide Efficacy in a Diet Induced Obesity Mouse Model October 17, 2023
CRB-913: A Novel Oral Cannabinoid Receptor-1 (CB1R) Inverse Agonist Enhances Tirzepatide and Semaglutide Efficacy in a Diet Induced Obesity Mouse Model Poster October 17, 2023
CRB-601 Unlocking the Potential of αvβ8 Blockade – Antitumor Activity and Immune Remodeling May 3, 2023
